People
Foventa makes key CMO and CFO appointments
3 September 2026 - Foventa Therapeutics, a biotechnology company focused on novel therapies for retinal vascular diseases, announced on Wednesday that it has further strengthened its management team w...
BioCare climbs 1,145 places on Inc. 5000 list
13 August 2026 - BioCare, a specialty pharmaceutical distributor comprised of BioCareSD and LogiCare3PL, announced on Wednesday that Inc. Magazine has named the company in the 2026 Inc. 5000, its annu...
DuPont recognised with R&D 100 Award for innovation in healthcare
7 August 2026 - US chemical company DuPont (NYSE:DD) announced on Thursday that it has won a 2026 R&D 100 Award in the Mechanical/Materials category, for its DuPont Liveo Pharma TPE Ultra-Low Temp...
Synaptiq Therapeutics launches and acquires clinical-stage SYN-001 programme
24 July 2026 - A consortium of European and US-based investors and clinical-stage company Nobias Therapeutics, which is majority-backed by Medical Excellence Capital, announced on Thursday the launch ...
WuXi AppTec named to FTSE4Good Index Series for fourth consecutive year
22 July 2026 - WuXi AppTec, a China-based global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organisation), announced on Tuesday that it has been named in the FTSE4Good Ind...
Kibow Biotech receives AANP Corporation of the Year Award
20 July 2026 - Kibow Biotech, a developer of probiotic supplements for maintaining kidney health, announced on Friday that it has been named the recipient of The American Association of Naturopathic P...